![]() |
市场调查报告书
商品编码
1625204
2030 年微导管市场预测:按产品类型、材料类型、程序、最终用户和地区进行的全球分析Micro Catheters Market Forecasts to 2030 - Global Analysis By Product Type (Single Lumen, Dual Lumen, Triple Lumen, Multidirectional and Other Product Types), Material Type, Procedure, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球微导管市场规模将达到 21 亿美元,预计到 2030 年将达到 31 亿美元,预测期内复合年增长率为 6.5%。
微导管是一种小型柔性管,用于医疗程序中,用于处理或收集体内特定区域的样本。它们的直径通常小于 2 毫米,旨在精确进入狭窄或难以到达的区域,例如血管或神经系统。微导管通常用于介入放射学、心臟病学和神经病学等领域,用于栓塞、切片检查和药物传输等手术,以微创方式改善患者的治疗效果。
根据《2023年世界心臟报告》,全球有超过5亿人受到心血管疾病的影响,2021年将有2,050万人死亡,几乎占全球死亡人数的三分之一。这比先前估计值的 1.21 亿 CVD 相关死亡人数有所增加,凸显了日益严重的全球健康危机。
慢性病增加
心血管疾病、糖尿病、神经系统疾病等慢性病的盛行率不断上升,推动了市场需求。这些先进的设备可实现微创手术,具有恢復更快、併发症更少等优点。随着全球人口老化和慢性病的盛行率增加,微导管市场正在扩大,这些设备在改善患者预后和提高治疗效率方面发挥关键作用。
产品缺陷和召回
市场上的产品缺陷或召回可能会产生严重的不利影响,包括消费者信心下降、市场占有率下降、监管力度加大。除了供应链潜在的中断之外,此类事件还可能因赔偿成本和诉讼而给製造商带来经济损失。此外,产品缺陷引起的安全问题可能会阻碍医疗保健专业人员使用这些设备,从而阻碍市场成长和创新。
微创手术日益偏好青睐
对微创手术日益增长的偏好正在显着推动市场发展。患者和医疗保健专业人员越来越喜欢这些手术,因为它们比传统手术具有优势,包括更快的恢復时间、更低的感染风险和更少的创伤。微导管能够实现精确、有针对性的治疗,满足了这一趋势并提高了治疗效率。随着对微创解决方案的需求不断增加,微导管在现代医学的发展中发挥关键作用。
缺乏熟练的专业人员
市场上缺乏熟练的专业人员构成了重大挑战,因为它阻碍了这些先进医疗设备的有效使用和实施。训练和专业知识不足可能会导致手术不当、併发症风险增加以及患者预后不佳。这种技能差距还会限制市场创新和扩张的潜力,减缓微创治疗的成长,并降低医疗保健效率。
COVID-19 的爆发对市场产生了负面影响,导致择期手术的延误和全球供应链的中断。医院优先考虑紧急护理,减少了对非紧急护理的需求。此外,旅行和国际贸易限制也影响了医疗设备的分配。然而,疫情也可能加速远端医疗和远距监测的普及,间接增加对微导管等微创手术的需求。
预计单流明部分在预测期内将是最大的
预计单流明细分市场将在预测期内占据最大的市场占有率。其简单紧凑的设计使其成为微创治疗的理想选择,可精确进入目标区域,特别是在血管成形术和神经血管介入治疗等手术中。这些导管的需求不断增长,因为它们能够有效缩短患者康復时间、最大限度地减少併发症并能够有效治疗各种慢性疾病。
预计神经血管部分在预测期内复合年增长率最高
神经血管段预计在预测期内复合年增长率最高,因为它是治疗动脉瘤和中风等疾病的重要设备。微导管精确地引导脆弱的神经血管通路并实现微创治疗。由于导管设计的进步、改善患者的治疗效果、缩短恢復时间以及为传统手术方法提供更安全的替代方案,它们在神经血管介入治疗中的使用越来越多。
由于医疗基础设施的进步和对微创手术的需求不断增加,预计北美地区在预测期内将占据最大的市场占有率。该地区强大的医疗保健系统和微导管设计创新正在支持市场扩张。此外,该地区人口老化和医疗成本上升导致对这些设备的需求增加,使其成为微导管製造商的重要市场。
预计亚太地区在预测期内将实现最高成长率。扩大医疗基础设施,特别是在新兴市场,正在改善患者获得先进医疗服务的机会。它也提高了人们对微创手术益处的认识。此外,微导管设计开发的进步,包括灵活性、耐用性和可操纵性的提高,使这些设备能够更有效地治疗各种病症,从而进一步提高其采用率。
According to Stratistics MRC, the Global Micro Catheters Market is accounted for $2.1 billion in 2024 and is expected to reach $3.1 billion by 2030 growing at a CAGR of 6.5% during the forecast period. Micro catheters are small, flexible tubes used in medical procedures to deliver treatments or collect samples from specific areas within the body. Typically measuring less than 2 millimeters in diameter, they are designed for precision access to narrow or hard-to-reach areas, such as blood vessels or the nervous system. Micro catheters are commonly used in interventional radiology, cardiology, and neurology for procedures like embolization, biopsy, or drug delivery, offering minimal invasiveness and improved patient outcomes.
According to the WORLD HEART REPORT 2023, over half a billion people worldwide were affected by cardiovascular diseases, which caused 20.5 million deaths in 2021, accounting for nearly a third of all global deaths. This marked an increase from the previous estimate of 121 million CVD-related deaths, emphasizing the growing global health crisis.
Increasing prevalence of chronic diseases
The increasing prevalence of chronic diseases, such as cardiovascular conditions, diabetes, and neurological disorders, is driving the demand for market. These advanced devices enable minimally invasive procedures, offering benefits like faster recovery and reduced complications. As the aging population grows and the incidence of chronic diseases rises globally, the micro catheter market is expanding, with these devices playing a crucial role in improving patient outcomes and enhancing treatment efficiency.
Product failures and recalls
Product failures and recalls in the market can have severe negative effects, including diminished consumer trust, reduced market share, and increased regulatory scrutiny. Such incidents may lead to financial losses for manufacturers due to compensation costs and lawsuits, alongside potential disruptions in the supply chain. Furthermore, safety concerns raised by product defects could discourage healthcare professionals from using these devices, hampering market growth and innovation.
Rising preference for minimally invasive procedures
Rising preference for minimally invasive procedures is significantly boosting the market. Patients and healthcare professionals increasingly favor these techniques due to their benefits, such as shorter recovery times, reduced risk of infections, and fewer traumas compared to traditional surgeries. Micro catheters, enabling precise and targeted treatments, align with this trend, offering enhanced procedural efficiency. As demand for less invasive solutions grows, micro catheters play a critical role in advancing modern medical practices.
Lack of skilled professionals
The lack of skilled professionals in the market poses a significant challenge, as it can hinder the effective use and adoption of these advanced medical devices. Inadequate training or expertise may lead to improper procedures, increased risk of complications, and suboptimal patient outcomes. This skills gap also limits the potential for innovation and expansion in the market, slowing the growth of minimally invasive treatments and potentially reducing healthcare efficiency.
The COVID-19 pandemic negatively impacted the market, causing delays in elective procedures and disruptions in the global supply chain. Hospitals prioritized urgent care, leading to a decline in demand for non-emergency treatments. Additionally, restrictions on travel and international trade affected the distribution of medical devices. However, the pandemic also accelerated the adoption of telemedicine and remote monitoring, which may indirectly drive future demand for minimally invasive procedures like those involving micro catheters.
The single lumen segment is expected to be the largest during the forecast period
The single lumen segment is expected to account for the largest market share during the projection period. Their simplicity and compact design make them ideal for minimally invasive treatments, offering precise access to target areas, especially in procedures like angioplasty or neurovascular interventions. The growing demand for these catheters is driven by their effectiveness in reducing patient recovery time, minimizing complications, and enabling efficient treatment of various chronic conditions.
The neurovascular segment is expected to have the highest CAGR during the forecast period
The neurovascular segment is expected to have the highest CAGR during the extrapolated period as these devices are crucial for treating conditions like aneurysms, strokes. Micro catheters allow for precise navigation through delicate neurovascular pathways, enabling minimally invasive treatments. Their growing use in neurovascular interventions is driven by advancements in catheter design, improving patient outcomes, reducing recovery time, and offering safer alternatives to traditional surgical methods.
North America region is projected to account for the largest market share during the forecast period driven by advancements in healthcare infrastructure and increasing demand for minimally invasive procedures. The region's strong healthcare system, coupled with technological innovations in micro catheter designs, supports market expansion. Furthermore, the region's aging population and high healthcare expenditure contribute to the growing demand for these devices, making it a key market for micro catheter manufacturers.
Asia Pacific is expected to register the highest growth rate over the forecast period. The expanding healthcare infrastructure, especially in emerging markets, is improving patient access to advanced medical treatments. This is also leading to greater awareness of the benefits of minimally invasive procedures. Additionally, ongoing developments in micro catheter designs, such as improved flexibility, durability, and steerability, have made these devices more effective in treating a wide range of conditions, further driving their adoption.
Key players in the market
Some of the key players in Micro Catheters market include Abbott Laboratories, Medtronic, Johnson & Johnson, Boston Scientific, Terumo Corporation, Stryker Corporation, Cardinal Health, Teleflex Incorporated, Philips Healthcare, Penumbra, Inc., Biotronik, Smith & Nephew, Cook Group, Lumenis, Fujifilm Holdings Corporation and MicroVention, Inc.
In June 2024, MicroVention, Inc. (Terumo Corporation) launched the LVIS EVO, a next-generation coil-assist intracranial stent, in the U.S. It treats wide-neck intracranial aneurysms. It offers enhanced precision and flexibility for neurovascular procedures.
In February 2024, BIOTRONIK and IMDS introduced the Micro RX catheter, a highly flexible microcatheter designed for complex coronary interventions. The catheter enhances precision during procedures, offering greater navigation capabilities in challenging anatomies. Its improved design facilitates optimal performance for clinicians performing intricate vascular procedures.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.